Id: | acc1438 |
Group: | 2sens |
Protein: | p70S6K |
Gene Symbol: | RPS6KB1 |
Protein Id: | P23443 |
Protein Name: | KS6B1_HUMAN |
PTM: | phosphorylation |
Site: | Ser371 |
Site Sequence: | ARKVEPPFKPLLQSEEDVSQF |
Disease Category: | Cancer |
Disease: | Lung Cancer |
Disease Subtype: | NSCLC |
Disease Cellline: | |
Disease Info: | |
Drug: | Ku0063794 |
Drug Info: | "KU-0063794 is a cell-permeable, selective dual inhibitor of mTORC1 and mTORC2 (IC50 =10 nM) that induces G1 cell cycle arrest and autophagy, inhibits tumor growth in renal cell carcinoma xenograft models, and does not affect the activity of 76 other protein kinases or seven lipid kinases, including PI3Ks. " |
Effect: | increase |
Effect Info: | "In tumors expressing high levels of total or phosphorylated p70S6K, ku - 0063794 may exert a greater anti - tumor effect." |
Note: | |
Score: | 5.0 |
Pubmed(PMID): | 23874880 |
Sentence Index: | 23874880_8-9 |
Sentence: | Akt ser473 phosphorylation which would be induced by rapamycin and resulted in partial inhibition of FOXO1 phosphorylation. We also observed that EGFR TKI-sensitive and -resistant clinical NSCLC tumor specimens had higher total and phosphorylated p70S6K expression levels. |
Sequence & Structure:
MRRRRRRDGFYPAPDFRDREAEDMAGVFDIDLDQPEDAGSEDELEEGGQLNESMDHGGVGPYELGMEHCEKFEISETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQVFLGFTYVAPSVLESVKEKFSFEPKIRSPRRFIGSPRTPVSPVKFSPGDFWGRGASASTANPQTPVEYPMETSGIEQMDVTMSGEASAPLPIRQPNSGPYKKQAFPMISKRPEHLRMNL
Select PDB:
Target | Drug name | MOA | Phase | Status | Disease | Source |
---|---|---|---|---|---|---|
RPS6KB1 | TAS0612 | Ribosomal protein S6 kinase (P70S6K) inhibitor | 1 | Recruiting | neoplasm | ClinicalTrials |
RPS6KB1 | MSC-2363318A | Ribosomal protein S6 kinase (P70S6K) inhibitor | 1 | Completed | neoplasm | ClinicalTrials |
RPS6KB1 | LY-2780301 | Ribosomal protein S6 kinase (P70S6K) inhibitor | 1 | Completed | lymphoma | ClinicalTrials |
RPS6KB1 | XL-418 | Ribosomal protein S6 kinase (P70S6K) inhibitor | 1 | Suspended | neoplasm | ClinicalTrials |
RPS6KB1 | LY-2584702 | Ribosomal protein S6 kinase 1 inhibitor | 1 | Terminated | renal cell carcinoma | ClinicalTrials |
RPS6KB1 | LY-2584702 | Ribosomal protein S6 kinase 1 inhibitor | 1 | Terminated | non-small cell lung carcinoma | ClinicalTrials |
RPS6KB1 | LY-2584702 | Ribosomal protein S6 kinase 1 inhibitor | 1 | Terminated | metastasis | ClinicalTrials |
RPS6KB1 | LY-2780301 | Ribosomal protein S6 kinase (P70S6K) inhibitor | 1 | Completed | metastasis | ClinicalTrials |
RPS6KB1 | LY-2584702 | Ribosomal protein S6 kinase 1 inhibitor | 1 | Terminated | neuroendocrine neoplasm | ClinicalTrials |
RPS6KB1 | LY-2584702 | Ribosomal protein S6 kinase 1 inhibitor | 1 | Completed | cancer | ClinicalTrials |
RPS6KB1 | LY-2584702 | Ribosomal protein S6 kinase 1 inhibitor | 1 | Terminated | cancer | ClinicalTrials |
RPS6KB1 | XL-418 | Ribosomal protein S6 kinase (P70S6K) inhibitor | 1 | Suspended | cancer | ClinicalTrials |
Note: Only show clinically investigational or approved drugs with protein targets.
Protein Tractability:
source: Open TargetsPTM Intensity:
source: CPTACRPS6KB1-Ser371 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | -0.707 |
HGSC | |
ccRCC | 0.707 |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
PTM-Disease Association:
source: PTMDResidue | Position | State | Disease | Class | PMID |
---|---|---|---|---|---|
S | 371 | U | Pancreatic ductal adenocarcinoma | Phosphorylation | 27014871 |
State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.